Skip to main content

Inhibition of 5-lo Activating Protein (Flap) Activity Decreases Proteinuria in Streptozotocin(Stz)-induced Diabetic Rats.

  • Chapter
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 507))

Abstract

Proteinuria is a major cause of morbidity in patients with glomerular disease. Nonselective protein filtration is now recognized as a significant contributing factor to the tubulo-interstitial injury which underlies and often predicts progressive renal insufficiency in patients with primary glomerular diseases. Increasing recognition of the mechanisms whereby proteinuria leads to tubule injury confirms the well-known clinical observation that the magnitude of proteinuria at diagnosis is a reliable predictor of prognosis in patients with glomerulonephritis and diabetes. For this reason, the search for safe and effective anti-proteinuric agents which do not reduce the glomerular filtration rate represents an urgent and critical need for physicians involved in the care of patients with glomerular disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. D. K. Miller, J. W. Gillard, P. J. Vickers, S. Sadowski, C. Leveille, J. A. Mancini, P. Charleson, R. A. F. Dixon, A. W. Ford-Hutchinson, R. Fortin, J. Y. Gauthier, J. Rodkey, R. Rosen, C. Rouzer, I. S. Sigal, C. D. Strader, and J. F. Evans. Identification and isolation of a membrane protein necessary for leukotriene production.Nature343: 278–281, (1990).

    Article  CAS  PubMed  Google Scholar 

  2. R. A. F. Dixon, R. E. Diehl, E. Opas, E. Rands, P. J. Viskers, J. F. Evans, J. W. Gillard, and D. K. Miller. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.Nature343: 282–284, (1990).

    Article  CAS  PubMed  Google Scholar 

  3. S. Uda, K. A. Munger, and K. F. Badr. Glomerular localization of 5-lipoxygenase (5-LO) and 5-LO activating protein (FLAP) in a rat model of proliferative glomerulonephritis.J Am Soc Nephrol8, (1997).

    Google Scholar 

  4. A. Guash, C. F. Zayas, and K. F. Badr. MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.Kidney /nt56, (1999).

    Google Scholar 

  5. S. Shankland, and J. Scholey. Expression of transforming growth factor-(31 during diabetic renal hypertrophy.Kidney /nt46: 430–442, (1994).

    Article  CAS  Google Scholar 

  6. J. Valdivielso, F. Perez-Barriocanal, J. García-Estañ, and J. López-Novoa. Role of nitric oxide in the early renal hemodynamic response after unilateral nephrectomy.American Journal of Physiology276: R1718- R1723, (1999).

    Google Scholar 

  7. K. Munger, A. Montero, M. Fukunaga, S. Uda, T. Yura, E. Imai, Y. Kaneda, J. Valdivielso, and K. Badr. Transfection of rat kidney with human 15-lipoxigenase suppresses inflammation and preserves function in experimental glomerulonephritis.PNAS96: 13375–13380, (1999).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. R. Arison, E. Ciaccio, M. Glitzer, J. Cassaro, and M. Pruss. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin.Diabetes16: 51–56, (1967).

    CAS  PubMed  Google Scholar 

  9. A. Junod, A. Lambert, L. Orci, R. Pictet, A. Gonet, and A. Renold. Studies of the diabetogenic action of streptozotocin.Proc Soc Exp Biol Med126: 201–205, (1967).

    Article  CAS  PubMed  Google Scholar 

  10. H. Selawry, J. Pennell, V. Pardo, D. Alzamora, and M. Millard. The effect of culture-mantained pancreatic islets on metabolic parameters, renal function, and glomerular lesions in the diabetic rat.Metabolism29: 261–269, (1980).

    Article  CAS  PubMed  Google Scholar 

  11. R. Weil, M. Nozawa, M. Koss, C. Weber, K. Reemstsama, and R. McIntosh. The kidney in streptozotocin diabetic rats.Arch Pathol Lab Med100: 37–49, (1976).

    CAS  PubMed  Google Scholar 

  12. J. Sheth. Diabetes, micrfoalbuminuria and hypertension.Clin and Exper Hypertension21: 61–68, (1999).

    Article  CAS  Google Scholar 

  13. V. Stewart, P. Whithing, A. Bell, and G. Hawsworth. Streptozotozin-induces diabetes is associated with increased renal lipoxygenase activity.Biochem Soc Transac26: S 134, (1998).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Valdivielso, J.M., Montero, A., Munger, K.A., Badr, K.F. (2002). Inhibition of 5-lo Activating Protein (Flap) Activity Decreases Proteinuria in Streptozotocin(Stz)-induced Diabetic Rats.. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E., Serhan, C. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5. Advances in Experimental Medicine and Biology, vol 507. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0193-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0193-0_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4960-0

  • Online ISBN: 978-1-4615-0193-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics